Robert Costa @costareports
What are the risks when clinical trials move quickly? Do they outweigh the benefits? Dr. Mark Gladwin of the University of Pittsburgh Medical Center weighs in. Plus, Robert Costa on the president’s actions, as Americans are desperate for a cure. https://t.co/g8QZ1Ftv5m — PolitiTweet.org